Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | -2.71% | 28.40 | 14.1% | $167.11m | |
| AMRN | Amarin Corp. Plc | -2.60% | 20.22 | 1.7% | $161.85m | |
| AXSM | Axsome Therapeutics, Inc. | -2.92% | 85.20 | 1.9% | $90.60m | |
| BHC | Bausch Health Cos., Inc. | -2.71% | 28.40 | 0.0% | $84.60m | |
| GWPH | GW Pharmaceuticals Plc | -1.20% | 114.51 | 6.2% | $73.62m | |
| JAZZ | Jazz Pharmaceuticals Plc | -2.25% | 145.74 | 2.3% | $63.95m | |
| PRGO | Perrigo Co. Plc | -1.24% | 58.74 | 6.8% | $63.73m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -3.02% | 96.65 | 16.9% | $61.51m | |
| SAVA | Cassava Sciences, Inc. | -7.18% | 7.18 | 0.0% | $60.84m | |
| SAGE | SAGE Therapeutics, Inc. | -3.46% | 68.02 | 8.6% | $58.61m | |
| HZNP | Horizon Therapeutics Plc | -2.83% | 36.06 | 6.6% | $56.41m | |
| MNK | Mallinckrodt Plc | -7.68% | 5.17 | 20.9% | $43.68m | |
| ICLR | ICON plc | 0.09% | 174.95 | 4.2% | $39.55m | |
| CTLT | Catalent, Inc. | 0.05% | 61.60 | 2.4% | $37.97m | |
| UTHR | United Therapeutics Corp. | -1.70% | 89.33 | 14.3% | $34.80m |
Company Profile
SAGE Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.